Jeremy Orr, MD, of University of California, San Diego, has been awarded the new ATS Foundation/ResMed Research Fellowship in Noninvasive Ventilation (NIV) in COPD.
Dr. Orr completed a fellowship in pulmonary and critical care medicine at UC San Diego School of Medicine, and a residency in internal medicine at UCLA’s David Geffen School of Medicine. He earned his medical degree from Washington University School of Medicine in St. Louis. Dr. Orr is board-certified in internal medicine, pulmonary disease and critical care medicine.
He is a member of the California Thoracic Society, American Academy of Sleep Medicine, American College of Chest Physicians, and American Thoracic Society.
ResMed is a global leader in NIV devices for treating COPD in the home and hospital.
Dr. Orr’s $100,000 award will support his research focused on the impact of noninvasive ventilation on cardiovascular biomarkers in COPD.
“Noninvasive ventilation during sleep is one of the few treatments in COPD that improves survival, but we don’t really understand the underlying mechanisms. This grant will facilitate my research into the potential systemic and extra-pulmonary benefits of NIV. As a junior physician-scientist, the impact of this foundation award on my career and research development is enormous,” said Dr. Orr.
“The more researchers learn about NIV’s effects on COPD, the more health care can effectively scale its efforts to improve patients’ disease management and quality of life,” said Carlos M. Nunez, M.D., ResMed’s Chief Medical Officer. “ResMed is proud to support ATS Foundation and Dr. Orr’s investigation into this life-changing therapy.”